Blocking monoclonal antibodies to agr2 and its receptor c4.4a

Abstract

Provided herein are monoclonal antibodies that recognize, bind to, and block interactions of other molecules with AGR2 and C4.4A. Also provided herein are methods of using said antibodies to treat cancer.